Intelgenx Technologies Stock

Intelgenx Technologies Revenue 2024

Intelgenx Technologies Revenue

1.04 M USD

Ticker

IGX.TO

ISIN

US45822R1014

WKN

A0RP0X

In 2024, Intelgenx Technologies's sales reached 1.04 M USD, a 9.37% difference from the 950,000 USD sales recorded in the previous year.

The Intelgenx Technologies Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
20231.04-66,79
20220.95-95,79
20211.54-46,75
20201.54-45,06
20190.74-93,78
20181.82100,00
20175.292,69
20165.2293,87
20155.191,37
20141.66-41,81
20130.95-73,05
20121.2-57,83
20110.44-157,73
20101.34-51,79
20091.28-54,22
20080.98-70,82
20070.86-80,70
20060.27-257,04
20050.02-3470,00

Intelgenx Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Intelgenx Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Intelgenx Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Intelgenx Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Intelgenx Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Intelgenx Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Intelgenx Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Intelgenx Technologies’s growth potential.

Intelgenx Technologies Revenue, EBIT and net profit per share

DateIntelgenx Technologies RevenueIntelgenx Technologies EBITIntelgenx Technologies Net Income
20231.04 M undefined-9.49 M undefined-9.93 M undefined
2022950,000 undefined-9.41 M undefined-10.69 M undefined
20211.54 M undefined-7.98 M undefined-9.31 M undefined
20201.54 M undefined-6.26 M undefined-7.04 M undefined
2019740,000 undefined-9.55 M undefined-10.66 M undefined
20181.82 M undefined-9 M undefined-10.11 M undefined
20175.2 M undefined-2.49 M undefined-3.05 M undefined
20165.22 M undefined-980,000 undefined-1.18 M undefined
20155.1 M undefined1.39 M undefined1.29 M undefined
20141.66 M undefined-1.78 M undefined-1.75 M undefined
2013950,000 undefined-1.64 M undefined-1.64 M undefined
20121.2 M undefined-2.26 M undefined-2.25 M undefined
2011440,000 undefined-2.44 M undefined-2.45 M undefined
20101.34 M undefined-3.01 M undefined-3.1 M undefined
20091.28 M undefined-1.38 M undefined-1.94 M undefined
2008980,000 undefined-2.32 M undefined-2.81 M undefined
2007860,000 undefined-710,000 undefined-1.1 M undefined
2006270,000 undefined-730,000 undefined-780,000 undefined
200520,000 undefined-130,000 undefined-130,000 undefined

Intelgenx Technologies stock margins

The Intelgenx Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Intelgenx Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Intelgenx Technologies.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Intelgenx Technologies's sales revenue. A higher gross margin percentage indicates that the Intelgenx Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Intelgenx Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Intelgenx Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Intelgenx Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Intelgenx Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Intelgenx Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Intelgenx Technologies Margin History

Intelgenx Technologies Gross marginIntelgenx Technologies Profit marginIntelgenx Technologies EBIT marginIntelgenx Technologies Profit margin
2023-66.79 %-913.47 %-955.44 %
2022-95.79 %-990.53 %-1,125.26 %
2021-46.75 %-518.18 %-604.55 %
2020-66.79 %-406.49 %-457.14 %
2019-66.79 %-1,290.54 %-1,440.54 %
2018100 %-494.51 %-555.49 %
201792.69 %-47.88 %-58.65 %
201693.87 %-18.77 %-22.61 %
201591.37 %27.25 %25.29 %
2014-66.79 %-107.23 %-105.42 %
2013-66.79 %-172.63 %-172.63 %
2012-66.79 %-188.33 %-187.5 %
2011-66.79 %-554.55 %-556.82 %
2010-66.79 %-224.63 %-231.34 %
2009-66.79 %-107.81 %-151.56 %
2008-66.79 %-236.73 %-286.73 %
2007-66.79 %-82.56 %-127.91 %
2006-66.79 %-270.37 %-288.89 %
2005-66.79 %-650 %-650 %

Intelgenx Technologies Aktienanalyse

What does Intelgenx Technologies do?

IntelGenx Technologies Corp is a Canadian company specializing in the development and manufacturing of orally dissolving films and other innovative pharmaceutical products. The company was founded in 2003 and has been listed on the Toronto Stock Exchange (TSX) since 2007. IntelGenx's history began with the development of a novel technology for the production of orally dissolving films called Versatile Film Technology (VFT). This technology allows for the creation of films that can administer active ingredients quickly and effectively without the need to be swallowed. Over the years, the company has evolved and expanded its product range to enable other innovative pharmaceutical formulations as well. IntelGenx's business model is based on licensing its technology and products to pharmaceutical companies and other organizations in the industry. The company offers a range of services, including formulation development, GMP-compliant product manufacturing, and support in submitting regulatory applications to the relevant authorities. IntelGenx is divided into several divisions tailored to the specific needs of its customers. The main division of the company is the production of orally dissolving films marketed under the brand name VersaFilm. These films are produced in various strengths and formulations and can be used for a variety of medical applications. Another significant division of IntelGenx is the development of products based on cannabinoids. The company has partnered with Tilray, a leading medical cannabis manufacturer, to develop a range of cannabinoid-based products available as orally dissolving films or capsule-based formulations. In addition to these two main divisions, IntelGenx also offers services in the field of polymer-based drug delivery. The company has partnered with a major pharmaceutical company to develop a variety of products based on this technology that can be used to treat diseases such as Alzheimer's and Parkinson's. Another important product offered by IntelGenx is the Sildenafil Oral Film, used to treat erectile dysfunction. This prescription medication is available in the United States and Canada and is considered a fast and convenient alternative to traditional formulations. In summary, IntelGenx Technologies Corp is an innovative company specializing in the development and manufacturing of orally dissolving films and other pharmaceutical products. The company's Versatile Film Technology (VFT) is a cutting-edge technology that allows for the quick and effective administration of active ingredients, and the company has developed a wide range of products and services to meet the needs of its customers. Intelgenx Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Intelgenx Technologies's Sales Figures

The sales figures of Intelgenx Technologies originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Intelgenx Technologies’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Intelgenx Technologies's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Intelgenx Technologies’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Intelgenx Technologies stock

How much revenue did Intelgenx Technologies generate this year?

Intelgenx Technologies has achieved a revenue of 1.04 M USD this year.

How much was the turnover of the company Intelgenx Technologies compared to the previous year?

The revenue of Intelgenx Technologies has increased by 9.37% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Intelgenx Technologies?

The revenue of Intelgenx Technologies is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Intelgenx Technologies measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Intelgenx Technologies so important for investors?

The revenue of Intelgenx Technologies is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Intelgenx Technologies pay?

Over the past 12 months, Intelgenx Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intelgenx Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Intelgenx Technologies?

The current dividend yield of Intelgenx Technologies is .

When does Intelgenx Technologies pay dividends?

Intelgenx Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intelgenx Technologies?

Intelgenx Technologies paid dividends every year for the past 0 years.

What is the dividend of Intelgenx Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intelgenx Technologies located?

Intelgenx Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intelgenx Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intelgenx Technologies from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Intelgenx Technologies pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Intelgenx Technologies in the year 2023?

In the year 2023, Intelgenx Technologies distributed 0 USD as dividends.

In which currency does Intelgenx Technologies pay out the dividend?

The dividends of Intelgenx Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Intelgenx Technologies stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Intelgenx Technologies

Our stock analysis for Intelgenx Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intelgenx Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.